Stock listing
NASDAQ:LMAT LeMaitre Vascular, Inc. Stock
Home listing (NASDAQ) of LeMaitre Vascular, Inc.
Follow LeMaitre Vascular, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LMAT
$73.61 USD -1.97 (-2.6%)
Close on Nov 20, 2026
- Day range
- $73.44 – $76.44 USDNov 20, 2026
- Volume
- 313,551 sharesNov 20, 2026
- Market cap
- $1.68B USDAt the close on Nov 20, 2026 · price × 22.88M shares outstanding
- 52-week range
- $73.44 – $118.01 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $22.62M USDMedian day 269,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LMAT · Home | $73.61 USD | -1.97 (-2.6%) | 313,551 | $74.34 | $76.44 | $73.44 | $75.58 | Close on Nov 20, 2026 |
| Frankfurt:LHU | €66.00 EUR | -1.00 (-1.5%) | — | €67.50 | €67.50 | €66.00 | €67.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LMAT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $73.61 | -1.97 | -2.6% | $74.34 | $76.44 | $73.44 | 313,551 | |
| $75.58 | -0.52 | -0.7% | $75.67 | $76.85 | $75.22 | 222,731 | |
| $76.10 | -0.91 | -1.2% | $76.83 | $77.53 | $75.67 | 190,505 | |
| $77.01 | -1.28 | -1.6% | $78.34 | $78.37 | $76.60 | 294,527 | |
| $78.29 | +0.64 | +0.8% | $78.00 | $80.21 | $77.91 | 200,052 | |
| $77.65 | -1.64 | -2.1% | $79.41 | $79.76 | $77.46 | 166,311 | |
| $79.29 | +0.27 | +0.3% | $78.76 | $80.08 | $78.75 | 137,325 | |
| $79.02 | -2.14 | -2.6% | $80.58 | $80.73 | $78.58 | 293,299 | |
| $81.16 | +0.27 | +0.3% | $81.85 | $81.92 | $79.98 | 185,927 | |
| $80.89 | -2.60 | -3.1% | $81.98 | $82.59 | $79.93 | 326,440 | |
| $83.49 | -4.43 | -5.0% | $81.79 | $85.97 | $80.73 | 533,765 | |
| $87.92 | +7.32 | +9.1% | $82.44 | $89.23 | $81.95 | 504,027 | |
| $80.60 | -0.66 | -0.8% | $81.26 | $82.12 | $80.47 | 423,696 | |
| $81.26 | +0.32 | +0.4% | $82.38 | $82.38 | $80.80 | 270,720 | |
| $80.94 | -4.33 | -5.1% | $85.53 | $85.53 | $80.03 | 426,419 | |
| $85.27 | +2.40 | +2.9% | $83.87 | $85.65 | $83.16 | 299,819 | |
| $82.87 | -0.92 | -1.1% | $83.38 | $84.54 | $82.49 | 360,736 | |
| $83.79 | -0.52 | -0.6% | $84.56 | $84.70 | $83.56 | 221,960 | |
| $84.31 | -0.14 | -0.2% | $84.80 | $85.81 | $84.06 | 270,578 | |
| $84.45 | -0.88 | -1.0% | $85.00 | $85.37 | $83.94 | 184,500 | |
| $85.33 | +1.66 | +2.0% | $84.06 | $85.63 | $83.21 | 212,800 | |
| $83.67 | +0.27 | +0.3% | $82.71 | $84.04 | $81.93 | 216,700 | |
| $83.40 | +1.09 | +1.3% | $83.16 | $83.90 | $82.84 | 238,000 | |
| $82.31 | +1.49 | +1.8% | $81.02 | $82.73 | $80.74 | 248,700 | |
| $80.82 | -2.34 | -2.8% | $82.53 | $84.24 | $80.69 | 311,500 | |
| $83.16 | +0.54 | +0.7% | $83.82 | $84.66 | $82.87 | 297,900 | |
| $82.62 | +1.07 | +1.3% | $81.26 | $82.92 | $80.81 | 316,000 | |
| $81.55 | -1.36 | -1.6% | $83.64 | $83.85 | $81.29 | 247,800 | |
| $82.91 | +2.22 | +2.8% | $80.77 | $83.25 | $80.03 | 257,900 | |
| $80.69 | +1.05 | +1.3% | $79.58 | $81.02 | $79.58 | 126,700 | |
| $79.64 | +0.33 | +0.4% | $79.31 | $80.16 | $78.31 | 272,900 | |
| $79.31 | +0.26 | +0.3% | $78.76 | $80.47 | $78.58 | 218,300 | |
| $79.05 | -1.94 | -2.4% | $81.04 | $81.21 | $78.90 | 283,400 | |
| $80.99 | +2.03 | +2.6% | $79.00 | $81.83 | $78.49 | 369,800 | |
| $78.96 | -1.23 | -1.5% | $81.36 | $81.36 | $78.66 | 325,700 | |
| $80.19 | -2.40 | -2.9% | $82.80 | $83.05 | $79.97 | 302,200 | |
| $82.59 | -0.30 | -0.4% | $82.81 | $83.35 | $81.82 | 207,900 | |
| $82.89 | +0.55 | +0.7% | $82.13 | $82.99 | $81.25 | 227,100 | |
| $82.34 | +0.82 | +1.0% | $81.29 | $82.82 | $80.39 | 238,900 | |
| $81.52 | +0.70 | +0.9% | $80.69 | $81.88 | $79.97 | 230,300 | |
| $80.82 | +0.24 | +0.3% | $80.64 | $81.37 | $79.67 | 321,300 | |
| $80.58 | -0.40 | -0.5% | $80.70 | $81.52 | $79.84 | 247,100 | |
| $80.98 | +1.78 | +2.2% | $79.84 | $81.32 | $79.69 | 260,900 | |
| $79.20 | +0.33 | +0.4% | $78.87 | $79.50 | $78.22 | 221,500 | |
| $78.87 | -0.60 | -0.8% | $79.25 | $79.60 | $78.51 | 399,400 | |
| $79.47 | -0.91 | -1.1% | $81.07 | $81.08 | $79.37 | 204,800 | |
| $80.38 | +0.14 | +0.2% | $79.53 | $80.84 | $79.48 | 256,900 | |
| $80.24 | -0.53 | -0.7% | $80.64 | $80.85 | $79.36 | 303,100 | |
| $80.77 | +0.18 | +0.2% | $81.39 | $81.82 | $80.00 | 247,900 | |
| $80.59 | +1.79 | +2.3% | $79.52 | $80.83 | $78.65 | 279,000 | |
| $78.80 | -0.67 | -0.8% | $78.91 | $80.25 | $78.29 | 291,100 | |
| $79.47 | -0.12 | -0.2% | $79.11 | $79.80 | $78.34 | 309,100 | |
| $79.59 | -1.08 | -1.3% | $79.93 | $80.38 | $79.07 | 222,300 | |
| $80.67 | +0.18 | +0.2% | $79.22 | $81.00 | $79.04 | 167,400 | |
| $80.49 | -1.23 | -1.5% | $82.57 | $83.07 | $80.00 | 299,000 | |
| $81.72 | +0.64 | +0.8% | $81.55 | $82.95 | $80.97 | 248,200 | |
| $81.08 | +0.80 | +1.0% | $80.39 | $81.85 | $79.59 | 346,500 | |
| $80.28 | -0.17 | -0.2% | $79.58 | $80.95 | $79.05 | 282,800 | |
| $80.45 | +0.78 | +1.0% | $80.17 | $80.97 | $79.15 | 217,800 | |
| $79.67 | +0.06 | +0.1% | $79.61 | $79.88 | $79.06 | 208,800 | |
| $79.61 | +0.64 | +0.8% | $78.91 | $79.81 | $78.27 | 150,400 | |
| $78.97 | -0.99 | -1.2% | $80.24 | $80.77 | $78.29 | 447,666 | |
| $79.96 | -1.90 | -2.3% | $81.94 | $82.74 | $79.65 | 561,996 | |
| $81.86 | -0.46 | -0.6% | $82.37 | $82.88 | $81.61 | 419,900 | |
| $82.32 | -1.55 | -1.8% | $83.07 | $83.55 | $81.98 | 269,400 |
- Ticker
- NASDAQ:LMAT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
LeMaitre to Participate in Upcoming Investor Conferences
Latest earnings call · Nov 4, 2026
LeMaitre Vascular (NASDAQ:LMAT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 23 slides
Latest news
LeMaitre to Participate in Upcoming Investor Conferences
Nov 6, 2026
Closed $81.16 (+0.3%) on Nov 9, 2026
LeMaitre Q3 2026 Financial Results
Nov 4, 2026
Closed $83.49 (-5.0%) on Nov 5, 2026
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
Oct 12, 2026
Closed $81.55 (-1.6%) on Oct 13, 2026
LeMaitre Q2 2026 Financial Results
Aug 4, 2026
Closed $79.00 (-25.3%) on Aug 5, 2026
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Jul 14, 2026
Closed $99.79 (+2.0%) on Jul 15, 2026
LeMaitre to Participate at Upcoming Investor Conferences in June
May 20, 2026
Closed $99.52 (-1.9%) on May 21, 2026
LeMaitre Q1 2026 Financial Results
May 5, 2026
Closed $110.22 (-1.6%) on May 6, 2026
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
Apr 14, 2026
Closed $114.81 (-2.2%) on Apr 15, 2026
LeMaitre Q4 2025 Financial Results
Feb 25, 2026
Closed $113.69 (+24.4%) on Feb 26, 2026
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
Feb 11, 2026
Closed $87.78 (-0.2%) on Feb 11, 2026
LeMaitre Vascular, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 10 in the last 12 months · 102 in all · newest Nov 6, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Nov 4, 2026
- Decks
- 5 decks · latest August 2026
Where LeMaitre Vascular, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LMAT · Home listing · This page | NASDAQ | United States | USD |
| gettex:LHU | gettex | Germany | EUR |
| LS Exchange:A0LB2B | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0LB2B | Lang & Schwarz | Germany | EUR |
| Tradegate:LHU | Tradegate | Germany | EUR |
| BOATS:LMAT | BOATS | United States | USD |
| Frankfurt:LHU | Frankfurt | Germany | EUR |
| Dusseldorf:LHU | Dusseldorf | Germany | EUR |
| Munich:LHU | Munich | Germany | EUR |
| Stuttgart:LHU | Stuttgart | Germany | EUR |
Valuation
P/E 26.6× against a median of 17.8×: 7th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.48B USD
- P/E
- 26.6×
- EV/sales
- 5.5×
- EV/EBITDA
- 17.4×
- Price/book
- 3.9×
- Gross margin
- 72.0%
- Operating margin
- 27.7%
- Net margin
- 23.5%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- 0.58
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. · NASDAQ:LMAT | US$1.68B | US$1.48B | 26.6× | 5.5× | 17.4× | 3.9× | 23.5% | 0.4× | 0.58 |
| Shandong Weigao Group Medical Polymer Co. Ltd. Class H · HKEX:1066 | US$1.80B | US$1.20B | 7.4× | 0.6× | 3.0× | 0.5× | 12.0% | 0.2× | n/a |
| Poly Medicure Limited · NSE:POLYMED | US$1.79B | US$1.70B | 52.1× | 7.4× | 32.6× | 5.1× | 14.9% | 0.0× | n/a |
| Top Glove Corporation Bhd. · MYX:TOPGLOV | US$1.79B | US$1.75B | 23.8× | 1.7× | 9.9× | 1.5× | 7.3% | 0.2× | n/a |
| Embla Medical hf · OMXCOP:EMBLA | US$1.71B | US$2.12B | 18.2× | 2.1× | 10.4× | 1.8× | 9.5% | 0.5× | n/a |
| Medartis Holding AG · SIX:MED | US$1.69B | US$1.91B | 170× | 6.0× | 58.5× | 5.0× | 3.1% | 0.7× | n/a |
| Dentsply Sirona Inc. · NASDAQ:XRAY | US$1.65B | US$3.44B | n/a | 1.0× | 12.1× | 1.2× | −3.4% | 1.5× | 1.03 |
| Angelalign Technology Inc. · HKEX:6699 | US$1.60B | −US$354.3M | 5.7× | −0.1× | −0.7× | 0.6× | 9.3% | 0.2× | n/a |
| Inspire Medical Systems, Inc. · NYSE:INSP | US$1.60B | US$1.27B | 15.8× | 1.4× | 36.9× | 1.9× | 11.4% | 0.0× | 1.00 |
| Shanghai MicroPort Endovascular MedTech Co., Ltd Class A · SSE:688016 | US$1.52B | US$1.21B | 17.4× | 5.5× | n/a | 2.4× | 40.1% | 0.0× | n/a |
| Vitrolife AB · OMXSTO:VITR | US$1.50B | US$1.58B | n/a | 4.7× | n/a | 1.9× | −144.2% | 0.2× | n/a |
| Median of the others | US$1.67B | US$1.64B | 17.8× | 1.9× | 11.3× | 1.9× | 9.4% | 0.2× | 1.02 |
Forecasts
2 strong buy · 2 buy · 4 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 99.29 USD · Analysts' mean
- EPS, year to Dec 2026
- 2.81 · 8 analysts
- Revenue, year to Dec 2026
- 276M · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| George W. LeMaitre | Chairman and CEO |
| Dorian LeBlanc | CFO |
| David B. Roberts | President, Board Director |
| Laurie Churchill | Chief Legal Officer |
| Gregory Manker | Director of Business Development and Investor Relations |
| Andrew Hodgkinson | SVP, Clinical, Regulatory & Quality Affairs |
| James Russell | VP, Production & Supply Chain |
| Jonathan W. Ngau | SVP, Information Technology |
| Roli Kumar-Choudhury | VP, Quality Affairs |
| Ryan H. Connelly | SVP, Advanced Manufacturing Engineering |
| Trent G. Kamke | SVP, Operations |
| Xiang Zhang | VP, Regulatory Affairs |
| Jacob Petersen | SVP, International |
Board
| Director | Role |
|---|---|
| George W. LeMaitre | Chairman and CEO |
| David B. Roberts | President, Board Director |
| John A. Roush | Board Director |
| John O'Connor | Board Director |
| Joseph P. Pellegrino | Board Director |
| Lawrence Jasinski | Board Director |
| Martha Shadan | Board Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| LeMaitre Vascular (NASDAQ:LMAT) Q3 2026 Earnings Call | Wed, Nov 04, 2026 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q1 2026 Earnings Call | Tue, May 05, 2026 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q4 2025 Earnings Call | Wed, Feb 25, 2026 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q1 2025 Earnings Call | Thu, May 15, 2025 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q3 2024 Earnings Call | Thu, Oct 31, 2024 · 5:00 PM ET | Replay |
| LeMaitre Vascular (NASDAQ:LMAT) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 5:00 PM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 4, 2026 · After close | −5.0% |
| Q2 2026 | Aug 4, 2026 · After close | −25.3% |
| Q1 2026 | May 5, 2026 · After close | −1.6% |
| Q4 2025 | Feb 25, 2026 | +25.3% |
| Q3 2025 | Nov 6, 2025 · After close | +1.4% |
| Q2 2025 | Aug 5, 2025 · After close | +8.9% |
| Q1 2025 | May 1, 2025 · After close | −12.8% |
| Q4 2024 | Feb 25, 2025 · After close | −0.9% |
| Q3 2024 | Oct 31, 2024 · After close | +7.3% |
| Q2 2024 | Aug 1, 2024 · After close | −1.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · After close | +11.2% |
| Q4 2023 | Feb 27, 2024 · After close | +14.4% |
| Q3 2023 | Nov 1, 2023 · After close | −2.5% |
| Q2 2023 | Aug 1, 2023 · After close | +3.0% |
| Q1 2023 | May 2, 2023 · After close | +15.2% |
| Q4 2022 | Feb 23, 2023 · After close | +4.3% |
| Q3 2022 | Oct 27, 2022 · After close | −19.1% |
| Q2 2022 | Jul 28, 2022 · After close | +3.1% |
| Q1 2022 | Apr 28, 2022 · After close | −5.7% |
| Q4 2021 | Feb 24, 2022 · After close | +1.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 23 slides | August 2026 |
| Q1 2026 Earnings Presentation | Earnings | 6 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 24 slides | Feb 25, 2026 |
| Q1 2025 Earnings Presentation | Earnings | 22 slides | May 15, 2025 |
| Investor Presentation (November 2013) | Investor deck | 59 slides | Nov 12, 2013 |
Financings
| Raise | Date |
|---|---|
| Convertible Senior Notes due 2030 Announced: US$150M Use of proceeds: Working capital and general purposes, possibly acquisitions of or investments in complementary companies, product lines, products or technologies | Dec 16, 2024 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 249.6M | 219.9M | 193.5M | 161.7M | 154.4M | 129.4M | 117.2M | 105.6M | 100.9M | 89.2M |
| Cost of revenue | 71.1M | 69.0M | 66.4M | 56.8M | 53.0M | 44.7M | 37.4M | 31.6M | 30.2M | 26.2M |
| Gross profit | 178.5M | 150.9M | 127.0M | 104.9M | 101.4M | 84.6M | 79.9M | 73.9M | 70.7M | 62.9M |
| Research and development | 14.1M | 15.7M | 17.0M | 13.3M | 11.8M | 10.1M | 9.28M | 8.20M | 6.64M | 6.14M |
| Selling, general and administrative | 42.0M | 36.3M | 31.8M | 28.7M | 25.5M | 22.5M | 19.1M | 17.7M | 17.0M | 14.4M |
| Operating income | 67.9M | 52.3M | 36.7M | 26.8M | 36.4M | 28.8M | 21.2M | 28.2M | 21.1M | 16.3M |
| Depreciation and amortization | 10.4M | 9.61M | 9.52M | 9.43M | 11.1M | 8.39M | 5.42M | 4.32M | 4.05M | 3.59M |
| EBITDA | 78.3M | 61.9M | 46.2M | 36.3M | 47.5M | 37.2M | 26.6M | 32.5M | 25.2M | 19.9M |
| Interest expense | 5.18M | 205.0K | 0 | 0 | 2.22M | 1.31M | 0 | 2.00K | 21.0K | 14.0K |
| Income before tax | 75.2M | 56.9M | 39.5M | 27.5M | 34.3M | 27.4M | 21.7M | 28.4M | 21.1M | 16.2M |
| Income tax | 17.4M | 12.8M | 9.37M | 6.85M | 7.38M | 6.14M | 3.75M | 5.50M | 3.93M | 5.65M |
| Net income | 57.7M | 44.0M | 30.1M | 20.6M | 26.9M | 21.2M | 17.9M | 22.9M | 17.2M | 10.6M |
| Earnings per share, basic | 2.55 | 1.96 | 1.36 | 0.94 | 1.27 | 1.05 | 0.91 | 1.18 | 0.91 | 0.57 |
| Earnings per share, diluted | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 | 1.04 | 0.88 | 1.13 | 0.86 | 0.55 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 28.2M | 25.6M | 24.3M | 19.1M | 13.9M | 26.8M | 11.8M | 26.3M | 19.1M | 24.3M |
| Short-term investments | 330.9M | 274.1M | 80.8M | 63.6M | 56.1M | 214.0K | 20.9M | 21.7M | 22.6M | 0 |
| Receivables | 33.6M | 30.1M | 25.1M | 22.0M | 19.6M | 19.6M | 16.6M | 15.7M | 15.0M | 13.2M |
| Inventory | 70.4M | 55.9M | 52.3M | 45.3M | 40.6M | 39.2M | 34.6M | 25.6M | 21.0M | 19.6M |
| Current assets | 468.2M | 402.2M | 194.6M | 161.7M | 139.9M | 94.3M | 92.1M | 94.0M | 80.3M | 59.0M |
| Property, plant and equipment | 27.0M | 24.8M | 21.8M | 17.9M | 17.1M | 15.0M | 14.9M | 14.1M | 12.4M | 8.01M |
| Goodwill | 65.9M | 65.9M | 65.9M | 65.9M | 65.9M | 65.9M | 40.0M | 29.9M | 23.8M | 23.4M |
| Total assets | 615.7M | 551.8M | 346.8M | 310.5M | 292.8M | 252.8M | 188.3M | 153.1M | 126.3M | 101.9M |
| Accounts payable | 3.65M | 1.76M | 3.73M | 2.90M | 2.34M | 2.39M | 2.60M | 1.73M | 1.54M | 1.22M |
| Current liabilities | 36.3M | 30.6M | 29.9M | 25.3M | 21.8M | 25.1M | 20.9M | 19.8M | 13.2M | 10.5M |
| Long-term debt | 168.6M | 167.8M | 35.5M | 0 | 0 | |||||
| Total debt | 185.6M | 185.7M | 19.1M | 16.6M | 15.9M | 54.8M | 15.7M | |||
| Total liabilities | 222.2M | 214.5M | 48.9M | 42.3M | 38.7M | 80.2M | 40.2M | 22.9M | 16.6M | 14.4M |
| Shareholders' equity | 393.5M | 337.3M | 297.9M | 268.2M | 254.2M | 172.6M | 148.1M | 130.2M | 109.8M | 87.5M |
| Shares outstanding | 22.8M | 22.5M | 22.8M | 22.8M | 22.6M | 22.3M | 22.1M | 21.9M | 20.5M | 20.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 81.3M | 44.1M | 36.8M | 25.4M | 35.1M | 34.8M | 14.2M | 19.5M | 22.9M | 16.9M |
| Capital spending | -6.78M | -6.96M | -7.26M | -3.23M | -4.88M | -2.98M | -3.76M | -3.05M | -6.42M | -2.84M |
| Free cash flow | 74.5M | 37.2M | 29.5M | 22.1M | 30.2M | 31.8M | 10.4M | 16.5M | 16.5M | 14.1M |
| Cash from investing | -64.9M | -200.1M | -24.7M | -10.4M | -61.1M | -52.9M | -24.1M | -7.05M | -29.0M | -17.2M |
| Cash from financing | -14.5M | 158.1M | -7.13M | -9.23M | 13.7M | 32.2M | -4.62M | -4.42M | 80.0K | -2.58M |
| Dividends paid | -18.1M | -14.4M | -12.4M | -11.0M | -9.34M | -7.70M | -6.74M | -5.45M | -4.18M | -3.32M |
| Share buybacks | -1.82M | -1.72M | -853.0K | -642.0K | -802.0K | -570.0K | -683.0K | -741.0K | -778.0K | -311.0K |
| Change in cash | 2.63M | 1.34M | 5.13M | 5.28M | -12.9M | 15.0M | -14.5M | 7.22M | -5.19M | -3.16M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 8-K · Current report | Oct 15, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Jul 29, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2026 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 23, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 14, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 14, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 14, 2026 | Management or board change | SEC |
| ARS · Annual report to shareholders | Apr 14, 2026 | Annual report | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 11, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 9, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2025 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Nov 6, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 4 · Change in ownership | Sep 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 8, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 8, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2025 | Results | SEC |
| 8-K · Current report | Jun 3, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 12, 2025 | Other filings | SEC |
| DEFA14A · Additional proxy material | May 8, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 29, 2025 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Apr 17, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 17, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 13, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 4, 2025 | Other filings | SEC |
This page holds 200 of 1,002 filings. Open Filings
Cap table
Built by 6ix from LeMaitre Vascular, Inc.’s releases · as of Nov 2, 2026
- Common shares
- 22,880,871
- Fully diluted
- 22,880,871
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 22,880,871 | Nov 2, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 2, 2026 | 22,880,871 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John A. Roush Other companies: Advanced Energy Industries, Inc. (Director · Since at least May 5, 2016); ESS Tech, Inc. (Chief Financial Officer, Director · Sep 16, 2020 – Oct 8, 2021 · Past); Novanta Inc. (Chief Executive Officer, Director · Dec 14, 2010 – Sep 1, 2016 · Past); Revvity, Inc. (Senior Vice President · Jan 31, 2006 – Feb 9, 2010 · Past) | Director · Since at least Apr 9, 2014 |
| Aaron M Grossman Other companies: Zoll Medical Corp (VP, Secretary and Gen Counsel · Nov 15, 2011 – Apr 26, 2012 · Past) | VP & General Counsel · Oct 18, 2006 – Sep 1, 2011 · Past |
| Bridget A Ross Other companies: Henry Schein, Inc. (President, Global Medical Grp · Feb 14, 2017 – Mar 6, 2017 · Past) | Director · Since at least Apr 28, 2020 |
| David B. Roberts Other companies: Anteris Technologies Global Corp. (Director · Since at least Jun 7, 2025) | President and Director, Director · Since at least Oct 21, 2020 |
| John O'Connor Other companies: Aspect Medical Systems Inc (Director · Dec 5, 2006 – Nov 6, 2009 · Past) | Board Director · Since at least Sep 17, 2008 |
| Joseph P Pellegrino Jr Other companies: Precision Optics Corporation, Inc. (Director · Since at least Mar 19, 2025) | Director · Since at least Oct 18, 2006 |
| Lawrence Jasinski Other companies: Lifeward Ltd. (Chief Executive Officer, Director · Dec 31, 2015 – May 21, 2025 · Past) | Board Director · Since at least Jul 26, 2010 |
| Martha Shadan Other companies: CVRx, Inc. (President and Chief Executive Officer · Since at least Jul 12, 2021) | Board Director · Since at least Sep 21, 2022 |
| Andrew Hodgkinson | SVP, Clinical, Regulatory & Quality Affairs · Since at least Nov 5, 2026 |
| Cornelia W LeMaitre | Director · Oct 18, 2006 – Aug 19, 2016 · Past |
All 28 people
| Person | Seat |
|---|---|
| Dorian LeBlanc | Chief Financial Officer · Since at least Mar 10, 2025 |
| George W. LeMaitre | Chairman and CEO · Since at least Oct 18, 2006 |
| Gregory Manker | Director of Business Development and Investor Relations · Since at least May 5, 2026 |
| Jacob Petersen | SVP, International · Since at least Nov 5, 2026 |
| James Russell | VP, Production & Supply Chain · Since at least Nov 4, 2026 |
| Jonathan W. Ngau | SVP, Information Technology · Since at least Oct 18, 2006 |
| Joseph P. Pellegrino | Board Director · Since at least Apr 23, 2026 |
| Kevin D Kelly | V. P. North American Sales · Oct 18, 2006 – Dec 22, 2007 · Past |
| Kimberly L Cieslak | Vice President, Marketing · Oct 18, 2006 – Feb 27, 2007 · Past |
| Laurie Churchill | Chief Legal Officer · Since at least Nov 5, 2026 |
| Michael H Thomas | Director · Jul 9, 2019 – Aug 9, 2019 · Past |
| Michael T Wijas | VP of Sales, The Americas · Aug 20, 2015 – Jun 8, 2017 · Past |
| Peter R Gebauer | President, International OP · Oct 18, 2006 – Sep 7, 2017 · Past |
| Roli Kumar-Choudhury | VP, Quality Affairs · Since at least Nov 5, 2026 |
| Russell D Hays | Director · Jul 27, 2009 – Mar 7, 2014 · Past |
| Ryan H. Connelly | SVP, Advanced Manufacturing Engineering · Since at least Oct 18, 2006 |
| Trent G. Kamke | SVP, Operations · Since at least Apr 22, 2013 |
| Xiang Zhang | VP, Regulatory Affairs · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about LeMaitre Vascular, Inc.